{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:45:52Z","timestamp":1792075552744,"version":"4.4.0"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"DOI":"10.1007\/s40265-026-02397-9","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:08:15Z","timestamp":1792073295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fatigue in Inflammatory Bowel Disease: The Role of Drug Therapy Within a Holistic Management Framework"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2527-7697","authenticated-orcid":false,"given":"Jai","family":"Sareen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8749-6398","authenticated-orcid":false,"given":"Madelaine","family":"Prichodko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0743-3189","authenticated-orcid":false,"given":"Lesley A.","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7969-3369","authenticated-orcid":false,"given":"Ali","family":"Keshavarzian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8010-0786","authenticated-orcid":false,"given":"Robin M.","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8041-3574","authenticated-orcid":false,"given":"Charles N.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"2397_CR1","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/j.1365-2036.2011.04871.x","volume":"34","author":"A Tinsley","year":"2011","unstructured":"Tinsley A, Macklin EA, Korzenik JR, Sands BE. Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011;34:1328\u201336. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04871.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"2397_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0022-3999(94)90099-x","volume":"38","author":"JH Vercoulen","year":"1994","unstructured":"Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38:383\u201392. https:\/\/doi.org\/10.1016\/0022-3999(94)90099-x.","journal-title":"J Psychosom Res"},{"key":"2397_CR3","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.crohns.2014.04.013","volume":"8","author":"W Czuber-Dochan","year":"2014","unstructured":"Czuber-Dochan W, Norton C, Bassett P, Berliner S, Bredin F, Darvell M, et al. Development and psychometric testing of inflammatory bowel disease fatigue (IBD-F) patient self-assessment scale. J Crohns Colitis. 2014;8:1398\u2013406. https:\/\/doi.org\/10.1016\/j.crohns.2014.04.013.","journal-title":"J Crohns Colitis"},{"key":"2397_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2036.2010.04347.x","volume":"32","author":"DR van Langenberg","year":"2010","unstructured":"van Langenberg DR, Gibson PR. Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther. 2010;32:131\u201343. https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04347.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"2397_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41575-018-0091-9","volume":"16","author":"NZ Borren","year":"2019","unstructured":"Borren NZ, van der Woude CJ, Ananthakrishnan AN. Fatigue in IBD: epidemiology, pathophysiology and management. Nat Rev Gastroenterol Hepatol. 2019;16:247\u201359. https:\/\/doi.org\/10.1038\/s41575-018-0091-9.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2397_CR6","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/ecco-jcc\/jjz024","volume":"13","author":"C Chavarr\u00eda","year":"2019","unstructured":"Chavarr\u00eda C, Casanova MJ, Chaparro M, Barreiro-de Acosta M, Ezquiaga E, Bujanda L, et al. Prevalence and factors associated with fatigue in patients with inflammatory bowel disease: a multicentre study. J Crohns Colitis. 2019;13:996\u20131002. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz024.","journal-title":"J Crohns Colitis"},{"key":"2397_CR7","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1097\/MEG.0000000000002178","volume":"33","author":"S van Gennep","year":"2021","unstructured":"van Gennep S, Gielen ME, Rietdijk ST, de Boer NKH, Duijvestein M, Gecse KB, et al. Work productivity loss is determined by fatigue and reduced quality of life in employed inflammatory bowel disease patients: a prospective multicentre cohort study. Eur J Gastroenterol Hepatol. 2021;33:e594. https:\/\/doi.org\/10.1097\/MEG.0000000000002178.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2397_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/apt.16145","volume":"53","author":"P Schreiner","year":"2021","unstructured":"Schreiner P, Rossel J-B, Biedermann L, Valko PO, Baumann CR, Greuter T, et al. Fatigue in inflammatory bowel disease and its impact on daily activities. Aliment Pharmacol Ther. 2021;53:138\u201349. https:\/\/doi.org\/10.1111\/apt.16145.","journal-title":"Aliment Pharmacol Ther"},{"key":"2397_CR9","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1002\/ibd.21580","volume":"17","author":"LA Graff","year":"2011","unstructured":"Graff LA, Vincent N, Walker JR, Clara I, Carr R, Ediger J, et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:1882\u20139. https:\/\/doi.org\/10.1002\/ibd.21580.","journal-title":"Inflamm Bowel Dis"},{"key":"2397_CR10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s12035-015-9090-9","volume":"53","author":"G Morris","year":"2016","unstructured":"Morris G, Berk M, Galecki P, Walder K, Maes M. The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases. Mol Neurobiol. 2016;53:1195\u2013219. https:\/\/doi.org\/10.1007\/s12035-015-9090-9.","journal-title":"Mol Neurobiol"},{"key":"2397_CR11","doi-asserted-by":"publisher","first-page":"v35","DOI":"10.1093\/rheumatology\/kez413","volume":"58","author":"SM Korte","year":"2019","unstructured":"Korte SM, Straub RH. Fatigue in inflammatory rheumatic disorders: pathophysiological mechanisms. Rheumatol Oxf Engl. 2019;58:v35-50. https:\/\/doi.org\/10.1093\/rheumatology\/kez413.","journal-title":"Rheumatol Oxf Engl."},{"key":"2397_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46\u201356. https:\/\/doi.org\/10.1038\/nrn2297.","journal-title":"Nat Rev Neurosci"},{"key":"2397_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.bbi.2007.05.005","volume":"21","author":"N Quan","year":"2007","unstructured":"Quan N, Banks WA. Brain-immune communication pathways. Brain Behav Immun. 2007;21:727\u201335. https:\/\/doi.org\/10.1016\/j.bbi.2007.05.005.","journal-title":"Brain Behav Immun"},{"key":"2397_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.yfrne.2012.09.003","volume":"33","author":"JC Felger","year":"2012","unstructured":"Felger JC, Miller AH. Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol. 2012;33:315\u201327. https:\/\/doi.org\/10.1016\/j.yfrne.2012.09.003.","journal-title":"Front Neuroendocrinol"},{"key":"2397_CR15","doi-asserted-by":"publisher","unstructured":"Bergamaschi G, Di Sabatino A, Albertini R, Ardizzone S, Biancheri P, Bonetti E, et al. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment. Haematologica. 2010;95:199\u2013205. https:\/\/doi.org\/10.3324\/haematol.2009.009985.","DOI":"10.3324\/haematol.2009.009985"},{"key":"2397_CR16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.crohns.2010.07.008","volume":"4","author":"M Voegtlin","year":"2010","unstructured":"Voegtlin M, Vavricka SR, Schoepfer AM, Straumann A, Voegtlin J, Rogler G, et al. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. J Crohns Colitis. 2010;4:642\u20138. https:\/\/doi.org\/10.1016\/j.crohns.2010.07.008.","journal-title":"J Crohns Colitis"},{"key":"2397_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","volume":"9","author":"AU Dignass","year":"2015","unstructured":"Dignass AU, Gasche C, Bettenworth D, Birgeg\u00e5rd G, Danese S, Gisbert JP, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9:211\u201322. https:\/\/doi.org\/10.1093\/ecco-jcc\/jju009.","journal-title":"J Crohns Colitis"},{"key":"2397_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0304293","volume":"20","author":"S Sartain","year":"2025","unstructured":"Sartain S, Al-Ezairej M, McDonnell M, Westoby C, Katarachia V, Wootton SA, et al. Iron deficiency and fatigue in inflammatory bowel disease: a systematic review. PLoS ONE. 2025;20:e0304293. https:\/\/doi.org\/10.1371\/journal.pone.0304293.","journal-title":"PLoS ONE"},{"key":"2397_CR19","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/ajg.2013.14","volume":"108","author":"BA Goldenberg","year":"2013","unstructured":"Goldenberg BA, Graff LA, Clara I, Zarychanski R, Walker JR, Carr R, et al. Is iron deficiency in the absence of anemia associated with fatigue in inflammatory bowel disease? Am J Gastroenterol. 2013;108:1392\u20137. https:\/\/doi.org\/10.1038\/ajg.2013.14.","journal-title":"Am J Gastroenterol"},{"key":"2397_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2021.101518","volume":"60","author":"A Ballesio","year":"2021","unstructured":"Ballesio A, Zagaria A, Baccini F, Micheli F, Di Nardo G, Lombardo C. A meta-analysis on sleep quality in inflammatory bowel disease. Sleep Med Rev. 2021;60:101518. https:\/\/doi.org\/10.1016\/j.smrv.2021.101518.","journal-title":"Sleep Med Rev"},{"key":"2397_CR21","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1111\/j.1440-1746.2006.04820.x","volume":"22","author":"Z Ranjbaran","year":"2007","unstructured":"Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 2007;22:1748\u201353. https:\/\/doi.org\/10.1111\/j.1440-1746.2006.04820.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"2397_CR22","doi-asserted-by":"publisher","first-page":"9231","DOI":"10.3748\/wjg.v19.i48.9231","volume":"19","author":"T Ali","year":"2013","unstructured":"Ali T, Choe J, Awab A, Wagener TL, Orr WC. Sleep, immunity and inflammation in gastrointestinal disorders. World J Gastroenterol. 2013;19:9231\u20139. https:\/\/doi.org\/10.3748\/wjg.v19.i48.9231.","journal-title":"World J Gastroenterol"},{"key":"2397_CR23","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00384-018-3032-8","volume":"33","author":"J Becker","year":"2018","unstructured":"Becker J, Berger F, Schindlbeck KA, Poddubnyy D, Koch PM, Prei\u00df JC, et al. Restless legs syndrome is a relevant comorbidity in patients with inflammatory bowel disease. Int J Colorectal Dis. 2018;33:955\u201362. https:\/\/doi.org\/10.1007\/s00384-018-3032-8.","journal-title":"Int J Colorectal Dis"},{"key":"2397_CR24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41577-019-0190-z","volume":"19","author":"MR Irwin","year":"2019","unstructured":"Irwin MR. Sleep and inflammation: partners in sickness and in health. Nat Rev Immunol. 2019;19:702\u201315. https:\/\/doi.org\/10.1038\/s41577-019-0190-z.","journal-title":"Nat Rev Immunol"},{"key":"2397_CR25","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/sleep\/30.9.1145","volume":"30","author":"M Haack","year":"2007","unstructured":"Haack M, Sanchez E, Mullington JM. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep. 2007;30:1145\u201352. https:\/\/doi.org\/10.1093\/sleep\/30.9.1145.","journal-title":"Sleep"},{"key":"2397_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1586\/eci.10.83","volume":"7","author":"GR Swanson","year":"2011","unstructured":"Swanson GR, Burgess HJ, Keshavarzian A. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare? Expert Rev Clin Immunol. 2011;7:29\u201336. https:\/\/doi.org\/10.1586\/eci.10.83.","journal-title":"Expert Rev Clin Immunol"},{"key":"2397_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097500","volume":"9","author":"RM Voigt","year":"2014","unstructured":"Voigt RM, Forsyth CB, Green SJ, Mutlu E, Engen P, Vitaterna MH, et al. Circadian disorganization alters intestinal microbiota. PLoS ONE. 2014;9:e97500. https:\/\/doi.org\/10.1371\/journal.pone.0097500.","journal-title":"PLoS ONE"},{"key":"2397_CR28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2025.06.017","author":"F Bishehsari","year":"2025","unstructured":"Bishehsari F, Post Z, Swanson GR, Keshavarzian A. Circadian rhythms in gastroenterology: the biological clock\u2019s impact on gut health. Gastroenterology. 2025. https:\/\/doi.org\/10.1053\/j.gastro.2025.06.017.","journal-title":"Gastroenterology"},{"key":"2397_CR29","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.4065\/81.10.1361","volume":"81","author":"TP Warrington","year":"2006","unstructured":"Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81:1361\u20137. https:\/\/doi.org\/10.4065\/81.10.1361.","journal-title":"Mayo Clin Proc"},{"key":"2397_CR30","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","volume":"390","author":"L Chaker","year":"2017","unstructured":"Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390:1550\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(17)30703-1.","journal-title":"Lancet"},{"key":"2397_CR31","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.clnu.2013.03.020","volume":"32","author":"S Massironi","year":"2013","unstructured":"Massironi S, Rossi RE, Cavalcoli FA, Della Valle S, Fraquelli M, Conte D. Nutritional deficiencies in inflammatory bowel disease: therapeutic approaches. Clin Nutr. 2013;32:904\u201310. https:\/\/doi.org\/10.1016\/j.clnu.2013.03.020.","journal-title":"Clin Nutr"},{"key":"2397_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","volume":"129","author":"CN Bernstein","year":"2005","unstructured":"Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology. 2005;129:827\u201336. https:\/\/doi.org\/10.1053\/j.gastro.2005.06.021.","journal-title":"Gastroenterology"},{"key":"2397_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.gtc.2017.09.007","volume":"47","author":"BN Limketkai","year":"2018","unstructured":"Limketkai BN, Wolf A, Parian AM. Nutritional interventions in the patient with inflammatory bowel disease. Gastroenterol Clin North Am. 2018;47:155\u201377. https:\/\/doi.org\/10.1016\/j.gtc.2017.09.007.","journal-title":"Gastroenterol Clin North Am"},{"key":"2397_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0163-7258(02)00297-8","volume":"96","author":"H Sch\u00e4cke","year":"2002","unstructured":"Sch\u00e4cke H, D\u00f6cke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002;96:23\u201343. https:\/\/doi.org\/10.1016\/s0163-7258(02)00297-8.","journal-title":"Pharmacol Ther"},{"key":"2397_CR35","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","volume":"68","author":"CA Lamb","year":"2019","unstructured":"Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68:s1-106. https:\/\/doi.org\/10.1136\/gutjnl-2019-318484.","journal-title":"Gut"},{"key":"2397_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","volume":"14","author":"J Torres","year":"2020","unstructured":"Torres J, Bonovas S, Doherty G, Kucharzik T, Gisbert JP, Raine T, et al. ECCO guidelines on therapeutics in Crohn\u2019s disease: medical treatment. J Crohns Colitis. 2020;14:4\u201322. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz180.","journal-title":"J Crohns Colitis"},{"key":"2397_CR37","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjx009","volume":"11","author":"M Harbord","year":"2017","unstructured":"Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management. J Crohns Colitis. 2017;11:769\u201384. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx009.","journal-title":"J Crohns Colitis"},{"key":"2397_CR38","first-page":"250","volume":"72","author":"A Cheifetz","year":"2005","unstructured":"Cheifetz A, Mayer L. Monoclonal antibodies, immunogenicity, and associated infusion reactions. Mt Sinai J Med N Y. 2005;72:250\u20136.","journal-title":"Mt Sinai J Med N Y."},{"key":"2397_CR39","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/apt.14852","volume":"48","author":"S Singh","year":"2018","unstructured":"Singh S, Fumery M, Sandborn WJ, Murad MH. Systematic review and network meta-analysis: first- and second-line biologic therapies for moderate-severe Crohn\u2019s disease. Aliment Pharmacol Ther. 2018;48:394\u2013409. https:\/\/doi.org\/10.1111\/apt.14852.","journal-title":"Aliment Pharmacol Ther"},{"key":"2397_CR40","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/ajg.2012.218","volume":"107","author":"GR Lichtenstein","year":"2012","unstructured":"Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Price S, et al. Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREATTM registry. Am J Gastroenterol. 2012;107:1409\u201322. https:\/\/doi.org\/10.1038\/ajg.2012.218.","journal-title":"Am J Gastroenterol"},{"key":"2397_CR41","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.cgh.2012.12.025","volume":"11","author":"M Ghabril","year":"2013","unstructured":"Ghabril M, Bonkovsky HL, Kum C, Davern T, Hayashi PH, Kleiner DE, et al. Liver injury from tumor necrosis factor-\u03b1 antagonists: analysis of thirty-four cases. Clin Gastroenterol Hepatol. 2013;11:558-564.e3. https:\/\/doi.org\/10.1016\/j.cgh.2012.12.025.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2397_CR42","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","volume":"86","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Mu\u00f1oz S, Soria N, Galiana D, Bertolaccini L, et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore). 2007;86:242\u201351. https:\/\/doi.org\/10.1097\/MD.0b013e3181441a68.","journal-title":"Medicine (Baltimore)"},{"key":"2397_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12325-019-01151-w","volume":"37","author":"A Nocerino","year":"2020","unstructured":"Nocerino A, Nguyen A, Agrawal M, Mone A, Lakhani K, Swaminath A. Fatigue in inflammatory bowel diseases: etiologies and management. Adv Ther. 2020;37:97\u2013112. https:\/\/doi.org\/10.1007\/s12325-019-01151-w.","journal-title":"Adv Ther"},{"key":"2397_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156666","volume":"11","author":"J Zeitz","year":"2016","unstructured":"Zeitz J, Ak M, M\u00fcller-Mottet S, Scharl S, Biedermann L, Fournier N, et al. Pain in IBD patients: very frequent and frequently insufficiently taken into account. PLoS ONE. 2016;11:e0156666. https:\/\/doi.org\/10.1371\/journal.pone.0156666.","journal-title":"PLoS ONE"},{"key":"2397_CR45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/apt.14108","volume":"46","author":"C Norton","year":"2017","unstructured":"Norton C, Czuber-Dochan W, Artom M, Sweeney L, Hart A. Systematic review: interventions for abdominal pain management in inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46:115\u201325. https:\/\/doi.org\/10.1111\/apt.14108.","journal-title":"Aliment Pharmacol Ther"},{"key":"2397_CR46","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","volume":"10","author":"A Latremoliere","year":"2009","unstructured":"Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10:895\u2013926. https:\/\/doi.org\/10.1016\/j.jpain.2009.06.012.","journal-title":"J Pain"},{"key":"2397_CR47","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrgastro.2015.121","volume":"12","author":"EA Mayer","year":"2015","unstructured":"Mayer EA, Labus JS, Tillisch K, Cole SW, Baldi P. Towards a systems view of IBS. Nat Rev Gastroenterol Hepatol. 2015;12:592\u2013605. https:\/\/doi.org\/10.1038\/nrgastro.2015.121.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2397_CR48","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1007\/s10620-021-07176-y","volume":"67","author":"JK Salwen-Deremer","year":"2022","unstructured":"Salwen-Deremer JK, Smith MT, Haskell HG, Schreyer C, Siegel CA. Poor sleep in inflammatory bowel disease is reflective of distinct sleep disorders. Dig Dis Sci. 2022;67:3096\u2013107. https:\/\/doi.org\/10.1007\/s10620-021-07176-y.","journal-title":"Dig Dis Sci"},{"key":"2397_CR49","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1037\/0033-2909.125.3.356","volume":"125","author":"C Eccleston","year":"1999","unstructured":"Eccleston C, Crombez G. Pain demands attention: a cognitive-affective model of the interruptive function of pain. Psychol Bull. 1999;125:356\u201366. https:\/\/doi.org\/10.1037\/0033-2909.125.3.356.","journal-title":"Psychol Bull"},{"key":"2397_CR50","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.pneurobio.2011.01.002","volume":"93","author":"O Moriarty","year":"2011","unstructured":"Moriarty O, McGuire BE, Finn DP. The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol. 2011;93:385\u2013404. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.01.002.","journal-title":"Prog Neurobiol"},{"key":"2397_CR51","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/s0885-3924(01)00267-6","volume":"21","author":"LM McCracken","year":"2001","unstructured":"McCracken LM, Iverson GL. Predicting complaints of impaired cognitive functioning in patients with chronic pain. J Pain Symptom Manag. 2001;21:392\u20136. https:\/\/doi.org\/10.1016\/s0885-3924(01)00267-6.","journal-title":"J Pain Symptom Manag"},{"key":"2397_CR52","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/npp.2016.143","volume":"42","author":"JC Felger","year":"2017","unstructured":"Felger JC, Treadway MT. Inflammation effects on motivation and motor activity: role of dopamine. Neuropsychopharmacology. 2017;42:216\u201341. https:\/\/doi.org\/10.1038\/npp.2016.143.","journal-title":"Neuropsychopharmacology"},{"key":"2397_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/ibd\/izy212","volume":"25","author":"E Ryan","year":"2019","unstructured":"Ryan E, McNicholas D, Creavin B, Kelly ME, Walsh T, Beddy D. Sarcopenia and inflammatory bowel disease: a systematic review. Inflamm Bowel Dis. 2019;25:67\u201373. https:\/\/doi.org\/10.1093\/ibd\/izy212.","journal-title":"Inflamm Bowel Dis"},{"key":"2397_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/apt.12372","volume":"38","author":"RV Bryant","year":"2013","unstructured":"Bryant RV, Trott MJ, Bartholomeusz FD, Andrews JM. Systematic review: body composition in adults with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38:213\u201325. https:\/\/doi.org\/10.1111\/apt.12372.","journal-title":"Aliment Pharmacol Ther"},{"key":"2397_CR55","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/MIB.0000000000000333","volume":"21","author":"PD Jones","year":"2015","unstructured":"Jones PD, Kappelman MD, Martin CF, Chen W, Sandler RS, Long MD. Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission. Inflamm Bowel Dis. 2015;21:1063\u201371. https:\/\/doi.org\/10.1097\/MIB.0000000000000333.","journal-title":"Inflamm Bowel Dis"},{"key":"2397_CR56","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/JSM.0b013e31802b4fda","volume":"17","author":"V Ng","year":"2007","unstructured":"Ng V, Millard W, Lebrun C, Howard J. Low-intensity exercise improves quality of life in patients with Crohn\u2019s disease. Clin J Sport Med. 2007;17:384\u20138. https:\/\/doi.org\/10.1097\/JSM.0b013e31802b4fda.","journal-title":"Clin J Sport Med"},{"key":"2397_CR57","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3748\/wjg.v27.i11.1076","volume":"27","author":"S-S Gong","year":"2021","unstructured":"Gong S-S, Fan Y-H, Lv B, Zhang M-Q, Xu Y, Zhao J. Fatigue in patients with inflammatory bowel disease in Eastern China. World J Gastroenterol. 2021;27:1076\u201389. https:\/\/doi.org\/10.3748\/wjg.v27.i11.1076.","journal-title":"World J Gastroenterol"},{"key":"2397_CR58","doi-asserted-by":"publisher","first-page":"175628482412719","DOI":"10.1177\/17562848241271987","volume":"17","author":"A Barnes","year":"2024","unstructured":"Barnes A, Bryant RV, Mukherjee S, Andrews JM, Bampton P, Fraser RJ, et al. Depression influences fatigue in inflammatory bowel disease amongst other factors: a structural modelling approach. Ther Adv Gastroenterol. 2024;17:17562848241271988. https:\/\/doi.org\/10.1177\/17562848241271987.","journal-title":"Ther Adv Gastroenterol"},{"key":"2397_CR59","doi-asserted-by":"publisher","unstructured":"Bernstein CN, Fisk JD, Dolovich C, Hitchon CA, Graff LA, El-Gabalawy R, et al. Understanding predictors of fatigue over time in persons with inflammatory bowel disease: the importance of depressive and anxiety symptoms. Am J Gastroenterol. 2024;119:922\u20139. https:\/\/doi.org\/10.14309\/ajg.0000000000002630.","DOI":"10.14309\/ajg.0000000000002630"},{"key":"2397_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/imj.70456","author":"A Chen","year":"2026","unstructured":"Chen A, Wong D. Fatigue and mood disorders are highly prevalent in patients with inflammatory bowel disease: a single-centre, cross-sectional study using patient-reported outcomes. Intern Med J. 2026. https:\/\/doi.org\/10.1111\/imj.70456.","journal-title":"Intern Med J"},{"key":"2397_CR61","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1016\/S0140-6736(16)30381-6","volume":"388","author":"MG Craske","year":"2016","unstructured":"Craske MG, Stein MB. Anxiety. Lancet. 2016;388:3048\u201359. https:\/\/doi.org\/10.1016\/S0140-6736(16)30381-6.","journal-title":"Lancet"},{"key":"2397_CR62","doi-asserted-by":"publisher","first-page":"1424926","DOI":"10.3389\/fmed.2024.1424926","volume":"11","author":"M Truyens","year":"2024","unstructured":"Truyens M, Lernout H, De Vos M, Laukens D, Lobaton T. Unraveling the fatigue puzzle: insights into the pathogenesis and management of IBD-related fatigue including the role of the gut-brain axis. Front Med. 2024;11:1424926. https:\/\/doi.org\/10.3389\/fmed.2024.1424926.","journal-title":"Front Med"},{"key":"2397_CR63","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1053\/smrv.2001.0162","volume":"5","author":"T Roehrs","year":"2001","unstructured":"Roehrs T, Roth T. Sleep, sleepiness, sleep disorders and alcohol use and abuse. Sleep Med Rev. 2001;5:287\u201397. https:\/\/doi.org\/10.1053\/smrv.2001.0162.","journal-title":"Sleep Med Rev"},{"key":"2397_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11920-017-0775-9","volume":"19","author":"KA Babson","year":"2017","unstructured":"Babson KA, Sottile J, Morabito D. Cannabis, cannabinoids, and sleep: a review of the literature. Curr Psychiatry Rep. 2017;19:23. https:\/\/doi.org\/10.1007\/s11920-017-0775-9.","journal-title":"Curr Psychiatry Rep"},{"key":"2397_CR65","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/j.1360-0443.2010.03351.x","volume":"106","author":"JM Boden","year":"2011","unstructured":"Boden JM, Fergusson DM. Alcohol and depression. Addiction. 2011;106:906\u201314. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03351.x.","journal-title":"Addiction"},{"key":"2397_CR66","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/jamapsychiatry.2015.3278","volume":"73","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, et al. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiat. 2016;73:292\u20137. https:\/\/doi.org\/10.1001\/jamapsychiatry.2015.3278.","journal-title":"JAMA Psychiat"},{"key":"2397_CR67","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.alcohol.2009.10.019","volume":"44","author":"GR Swanson","year":"2010","unstructured":"Swanson GR, Sedghi S, Farhadi A, Keshavarzian A. Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol. 2010;44:223\u20138. https:\/\/doi.org\/10.1016\/j.alcohol.2009.10.019.","journal-title":"Alcohol"},{"key":"2397_CR68","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.alcohol.2014.07.019","volume":"49","author":"MM Thakkar","year":"2015","unstructured":"Thakkar MM, Sharma R, Sahota P. Alcohol disrupts sleep homeostasis. Alcohol. 2015;49:299\u2013310. https:\/\/doi.org\/10.1016\/j.alcohol.2014.07.019.","journal-title":"Alcohol"},{"key":"2397_CR69","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","volume":"72","author":"DS Hasin","year":"2001","unstructured":"Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, et al. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiat. 2015;72:1235\u201342. https:\/\/doi.org\/10.1001\/jamapsychiatry.2015.1858.","journal-title":"JAMA Psychiat"},{"key":"2397_CR70","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.drugalcdep.2015.08.035","volume":"156","author":"A Weiss","year":"2015","unstructured":"Weiss A, Friedenberg F. Patterns of cannabis use in patients with inflammatory bowel disease: a population based analysis. Drug Alcohol Depend. 2015;156:84\u20139. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.08.035.","journal-title":"Drug Alcohol Depend"},{"key":"2397_CR71","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/01.MIB.0000440982.79036.d6","volume":"20","author":"M Storr","year":"2014","unstructured":"Storr M, Devlin S, Kaplan GG, Panaccione R, Andrews CN. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn\u2019s disease. Inflamm Bowel Dis. 2014;20:472\u201380. https:\/\/doi.org\/10.1097\/01.MIB.0000440982.79036.d6.","journal-title":"Inflamm Bowel Dis"},{"key":"2397_CR72","doi-asserted-by":"publisher","unstructured":"Iablokov V, Gregor J, Chande N, Ponich T, Jairath V, Khanna R, et al. Cannabis use in patients with inflammatory bowel disease following legalization of cannabis in Canada. Crohns Colitis 360. 2024;6:otae031. https:\/\/doi.org\/10.1093\/crocol\/otae031.","DOI":"10.1093\/crocol\/otae031"},{"key":"2397_CR73","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/MCG.0000000000001393","volume":"55","author":"BH Doeve","year":"2021","unstructured":"Doeve BH, van de Meeberg MM, van Schaik FDM, Fidder HH. A systematic review with meta-analysis of the efficacy of cannabis and cannabinoids for inflammatory bowel disease: what can we learn from randomized and nonrandomized studies? J Clin Gastroenterol. 2021;55:798\u2013809. https:\/\/doi.org\/10.1097\/MCG.0000000000001393.","journal-title":"J Clin Gastroenterol"},{"key":"2397_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012005.pub2","volume":"2020","author":"D Farrell","year":"2020","unstructured":"Farrell D, Artom M, Czuber\u2010Dochan W, Jelsness\u2010J\u00f8rgensen LP, Norton C, Savage E. Interventions for fatigue in inflammatory bowel disease. Cochrane Database Syst Rev. 2020;2020:CD012005. https:\/\/doi.org\/10.1002\/14651858.CD012005.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"2397_CR75","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s40265-023-01888-3","volume":"83","author":"BM Skjellerudsveen","year":"2023","unstructured":"Skjellerudsveen BM, Skoie IM, Dalen I, Grimstad T, Omdal R. The effect of biological treatment on fatigue in inflammatory bowel disease: a systematic review and meta-analysis. Drugs. 2023;83:909\u201321. https:\/\/doi.org\/10.1007\/s40265-023-01888-3.","journal-title":"Drugs"},{"key":"2397_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093116","volume":"12","author":"HH Lee","year":"2023","unstructured":"Lee HH, Gweon T-G, Kang S-G, Jung SH, Lee K-M, Kang S-B. Assessment of fatigue and associated factors in patients with inflammatory bowel disease: a questionnaire-based study. J Clin Med. 2023;12:3116. https:\/\/doi.org\/10.3390\/jcm12093116.","journal-title":"J Clin Med"},{"key":"2397_CR77","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/cei.13276","volume":"197","author":"CD Moulton","year":"2019","unstructured":"Moulton CD, Pavlidis P, Norton C, Norton S, Pariante C, Hayee B, et al. Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation? Clin Exp Immunol. 2019;197:308\u201318. https:\/\/doi.org\/10.1111\/cei.13276.","journal-title":"Clin Exp Immunol"},{"key":"2397_CR78","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1080\/03007995.2024.2380733","volume":"40","author":"TH Gibble","year":"2024","unstructured":"Gibble TH, Shan M, Zhou X, Naegeli AN, Dubey S, Lewis JD. Association of fatigue with disease activity and clinical manifestations in patients with Crohn\u2019s disease and ulcerative colitis: an observational cross-sectional study in the United States. Curr Med Res Opin. 2024;40:1537\u201344. https:\/\/doi.org\/10.1080\/03007995.2024.2380733.","journal-title":"Curr Med Res Opin"},{"key":"2397_CR79","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/apt.16465","volume":"54","author":"JJ McGing","year":"2021","unstructured":"McGing JJ, Radford SJ, Francis ST, Serres S, Greenhaff PL, Moran GW. Review article: the aetiology of fatigue in inflammatory bowel disease and potential therapeutic management strategies. Aliment Pharmacol Ther. 2021;54:368\u201387. https:\/\/doi.org\/10.1111\/apt.16465.","journal-title":"Aliment Pharmacol Ther"},{"key":"2397_CR80","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.2165\/00003495-200868130-00003","volume":"68","author":"R Kumar","year":"2008","unstructured":"Kumar R. Approved and investigational uses of modafinil. Drugs. 2008;68:1803\u201339. https:\/\/doi.org\/10.2165\/00003495-200868130-00003.","journal-title":"Drugs"},{"key":"2397_CR81","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/j.cgh.2023.12.030","volume":"22","author":"CD Moulton","year":"2024","unstructured":"Moulton CD, Young AH, Hart AL. Modafinil for severe fatigue in inflammatory bowel disease: a prospective case series. Clin Gastroenterol Hepatol. 2024;22:1737\u201340. https:\/\/doi.org\/10.1016\/j.cgh.2023.12.030.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2397_CR82","doi-asserted-by":"publisher","first-page":"15599","DOI":"10.1007\/s00210-025-03964-9","volume":"398","author":"MJ Amini","year":"2025","unstructured":"Amini MJ, Seighali N, Arabazadeh Bahri R, Ala M, Mohammad Jafari R, Dehpour AR. Repurposing of modafinil as an anti-inflammatory drug: a systematic review of experimental studies. Naunyn Schmiedebergs Arch Pharmacol. 2025;398:15599. https:\/\/doi.org\/10.1007\/s00210-025-03964-9.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2397_CR83","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s43440-019-00054-5","volume":"72","author":"P Dejban","year":"2020","unstructured":"Dejban P, Rahimi N, Takzare N, Dehpour AR. Biochemical and histopathological evidence for the beneficial effects of modafinil on the rat model of inflammatory bowel disease: involvement of nitric oxide pathway. Pharmacol Rep PR. 2020;72:135\u201346. https:\/\/doi.org\/10.1007\/s43440-019-00054-5.","journal-title":"Pharmacol Rep PR."},{"key":"2397_CR84","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/03602532.2019.1620763","volume":"51","author":"R Costa","year":"2019","unstructured":"Costa R, Oliveira NG, Dinis-Oliveira RJ. Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects. Drug Metab Rev. 2019;51:293\u2013313. https:\/\/doi.org\/10.1080\/03602532.2019.1620763.","journal-title":"Drug Metab Rev"},{"key":"2397_CR85","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.smrv.2011.12.003","volume":"16","author":"CW Berridge","year":"2012","unstructured":"Berridge CW, Schmeichel BE, Espa\u00f1a RA. Noradrenergic modulation of wakefulness\/arousal. Sleep Med Rev. 2012;16:187\u201397. https:\/\/doi.org\/10.1016\/j.smrv.2011.12.003.","journal-title":"Sleep Med Rev"},{"key":"2397_CR86","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.pnpbp.2012.10.006","volume":"48","author":"B Sperner-Unterweger","year":"2014","unstructured":"Sperner-Unterweger B, Kohl C, Fuchs D. Immune changes and neurotransmitters: possible interactions in depression? Prog Neuropsychopharmacol Biol Psychiatry. 2014;48:268\u201376. https:\/\/doi.org\/10.1016\/j.pnpbp.2012.10.006.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2397_CR87","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.intimp.2005.12.007","volume":"6","author":"D Brustolim","year":"2006","unstructured":"Brustolim D, Ribeiro-dos-Santos R, Kast RE, Altschuler EL, Soares MBP. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol. 2006;6:903\u20137. https:\/\/doi.org\/10.1016\/j.intimp.2005.12.007.","journal-title":"Int Immunopharmacol"},{"key":"2397_CR88","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s10753-020-01273-2","volume":"43","author":"A Rashidian","year":"2020","unstructured":"Rashidian A, Dejban P, Karami Fard K, Abdollahi A, Chamanara M, Dehpour A, et al. Bupropion ameliorates acetic acid-induced colitis in rat: the involvement of the TLR4\/NF-kB signaling pathway. Inflammation. 2020;43:1999\u20132009. https:\/\/doi.org\/10.1007\/s10753-020-01273-2.","journal-title":"Inflammation"},{"key":"2397_CR89","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/0269881113514878","volume":"28","author":"JA Cooper","year":"2014","unstructured":"Cooper JA, Tucker VL, Papakostas GI. Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union. J Psychopharmacol. 2014;28:118\u201324. https:\/\/doi.org\/10.1177\/0269881113514878.","journal-title":"J Psychopharmacol"},{"key":"2397_CR90","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jpainsymman.2022.09.011","volume":"65","author":"JE Correa-Morales","year":"2023","unstructured":"Correa-Morales JE, Cuellar-Valencia L, Mantilla-Manosalva N, Quintero-Mu\u00f1oz E, Iriarte-Aristiz\u00e1bal MF, Giraldo-Moreno S, et al. Cancer and non-cancer fatigue treated with bupropion: a systematic review. J Pain Symptom Manag. 2023;65:e21\u20138. https:\/\/doi.org\/10.1016\/j.jpainsymman.2022.09.011.","journal-title":"J Pain Symptom Manag"},{"key":"2397_CR91","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cgh.2020.09.047","volume":"20","author":"JG Hashash","year":"2022","unstructured":"Hashash JG, Knisely MR, Germain A, McAuliff K, Strassburger M, Vachon A, et al. Brief behavioral therapy and bupropion for sleep and fatigue in young adults with Crohn\u2019s disease: an exploratory open trial study. Clin Gastroenterol Hepatol. 2022;20:96\u2013104. https:\/\/doi.org\/10.1016\/j.cgh.2020.09.047.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2397_CR92","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1053\/j.gastro.2022.07.052","volume":"163","author":"M Truyens","year":"2022","unstructured":"Truyens M, Lobat\u00f3n T, Ferrante M, Bossuyt P, Vermeire S, Pouillon L, et al. Effect of 5-Hydroxytryptophan on fatigue in quiescent inflammatory bowel disease: a randomized controlled trial. Gastroenterology. 2022;163:1294-1305.e3. https:\/\/doi.org\/10.1053\/j.gastro.2022.07.052.","journal-title":"Gastroenterology"},{"key":"2397_CR93","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2017.08.028","volume":"153","author":"S Nikolaus","year":"2017","unstructured":"Nikolaus S, Schulte B, Al-Massad N, Thieme F, Schulte DM, Bethge J, et al. Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases. Gastroenterology. 2017;153:1504-1516.e2. https:\/\/doi.org\/10.1053\/j.gastro.2017.08.028.","journal-title":"Gastroenterology"},{"key":"2397_CR94","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/ajcn\/42.5.1072","volume":"42","author":"JD Fernstrom","year":"1985","unstructured":"Fernstrom JD. Dietary effects on brain serotonin synthesis: relationship to appetite regulation. Am J Clin Nutr. 1985;42:1072\u201382. https:\/\/doi.org\/10.1093\/ajcn\/42.5.1072.","journal-title":"Am J Clin Nutr"},{"key":"2397_CR95","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1089\/acm.2011.0840","volume":"19","author":"A Costantini","year":"2013","unstructured":"Costantini A, Pala MI. Thiamine and fatigue in inflammatory bowel diseases: an open-label pilot study. J Altern Complement Med. 2013;19:704\u20138. https:\/\/doi.org\/10.1089\/acm.2011.0840.","journal-title":"J Altern Complement Med"},{"key":"2397_CR96","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/apt.16166","volume":"53","author":"P Bager","year":"2021","unstructured":"Bager P, Hvas CL, Rud CL, Dahlerup JF. Randomised clinical trial: high-dose oral thiamine versus placebo for chronic fatigue in patients with quiescent inflammatory bowel disease. Aliment Pharmacol Ther. 2021;53:79\u201386. https:\/\/doi.org\/10.1111\/apt.16166.","journal-title":"Aliment Pharmacol Ther"},{"key":"2397_CR97","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/00365521.2021.1983640","volume":"57","author":"P Bager","year":"2022","unstructured":"Bager P, Hvas CL, Rud CL, Dahlerup JF. Long-term maintenance treatment with 300 mg thiamine for fatigue in patients with inflammatory bowel disease: results from an open-label extension of the TARIF study. Scand J Gastroenterol. 2022;57:37\u201343. https:\/\/doi.org\/10.1080\/00365521.2021.1983640.","journal-title":"Scand J Gastroenterol"},{"key":"2397_CR98","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clnesp.2017.10.004","volume":"23","author":"A-M Scholten","year":"2018","unstructured":"Scholten A-M, Vermeulen E, Dhonukshe-Rutten RAM, Verhagen T, Visscher A, Olivier A, et al. Surplus vitamin B12 use does not reduce fatigue in patients with Irritable Bowel Syndrome or inflammatory bowel disease: a randomized double-blind placebo-controlled trial. Clin Nutr ESPEN. 2018;23:48\u201353. https:\/\/doi.org\/10.1016\/j.clnesp.2017.10.004.","journal-title":"Clin Nutr ESPEN."},{"key":"2397_CR99","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14472","volume":"75","author":"S Moradi","year":"2021","unstructured":"Moradi S, Zobeiri M, Feizi A, Clark CCT, Entezari MH. The effects of spirulina (Arthrospira platensis) supplementation on anthropometric indices, blood pressure, sleep quality, mental health, fatigue status and quality of life in patients with ulcerative colitis: a randomised, double-blinded, placebo-controlled trial. Int J Clin Pract. 2021;75:e14472. https:\/\/doi.org\/10.1111\/ijcp.14472.","journal-title":"Int J Clin Pract"},{"key":"2397_CR100","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/00365521.2025.2608181","volume":"61","author":"ME Jahnsen","year":"2026","unstructured":"Jahnsen ME, Detlie TE, Eide GE, Moum B, Reime MH, Jahnsen J. High-dose intravenous iron improves quality of life in patients with inflammatory bowel disease and iron deficiency. Scand J Gastroenterol. 2026;61:192\u2013200. https:\/\/doi.org\/10.1080\/00365521.2025.2608181.","journal-title":"Scand J Gastroenterol"},{"key":"2397_CR101","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2023.11.303","volume":"166","author":"JG Hashash","year":"2024","unstructured":"Hashash JG, Elkins J, Lewis JD, Binion DG. AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review. Gastroenterology. 2024;166:521\u201332. https:\/\/doi.org\/10.1053\/j.gastro.2023.11.303.","journal-title":"Gastroenterology"},{"key":"2397_CR102","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013529.pub2","volume":"1","author":"M Gordon","year":"2021","unstructured":"Gordon M, Sinopoulou V, Iheozor-Ejiofor Z, Iqbal T, Allen P, Hoque S, et al. Interventions for treating iron deficiency anaemia in inflammatory bowel disease. Cochrane Database Syst Rev. 2021;1:CD013529. https:\/\/doi.org\/10.1002\/14651858.CD013529.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"2397_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217238","volume":"14","author":"CE Janssen","year":"2019","unstructured":"Janssen CE, Globig AM, Busse Grawitz A, Bettinger D, Hasselblatt P. Seasonal variability of vitamin D status in patients with inflammatory bowel disease - a retrospective cohort study. PLoS ONE. 2019;14:e0217238. https:\/\/doi.org\/10.1371\/journal.pone.0217238.","journal-title":"PLoS ONE"},{"key":"2397_CR104","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3109\/00365521.2013.836752","volume":"48","author":"F Bermejo","year":"2013","unstructured":"Bermejo F, Algaba A, Guerra I, Chaparro M, De-La-Poza G, Valer P, et al. Should we monitor vitamin B12 and folate levels in Crohn\u2019s disease patients? Scand J Gastroenterol. 2013;48:1272\u20137. https:\/\/doi.org\/10.3109\/00365521.2013.836752.","journal-title":"Scand J Gastroenterol"},{"key":"2397_CR105","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1097\/MEG.0000000000002821","volume":"36","author":"AY Kamel","year":"2024","unstructured":"Kamel AY, Johnson ZD, Hernandez I, Nguyen C, Rolfe M, Joseph T, et al. Micronutrient deficiencies in inflammatory bowel disease: an incidence analysis. Eur J Gastroenterol Hepatol. 2024;36:1186\u201392. https:\/\/doi.org\/10.1097\/MEG.0000000000002821.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2397_CR106","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005353","volume":"95","author":"A Nowak","year":"2016","unstructured":"Nowak A, Boesch L, Andres E, Battegay E, Hornemann T, Schmid C, et al. Effect of vitamin D3 on self-perceived fatigue: a double-blind randomized placebo-controlled trial. Medicine (Baltimore). 2016;95:e5353. https:\/\/doi.org\/10.1097\/MD.0000000000005353.","journal-title":"Medicine (Baltimore)"},{"key":"2397_CR107","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.301","volume":"4","author":"A Afzali","year":"2021","unstructured":"Afzali A, Goli S, Moravveji A, Bagheri H, Mirhosseini S, Ebrahimi H. The effect of zinc supplementation on fatigue among elderly community dwellers: a parallel clinical trial. Health Sci Rep. 2021;4:e301. https:\/\/doi.org\/10.1002\/hsr2.301.","journal-title":"Health Sci Rep"},{"key":"2397_CR108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176631","volume":"12","author":"ML Joustra","year":"2017","unstructured":"Joustra ML, Minovic I, Janssens KAM, Bakker SJL, Rosmalen JGM. Vitamin and mineral status in chronic fatigue syndrome and fibromyalgia syndrome: a systematic review and meta-analysis. PLoS ONE. 2017;12:e0176631. https:\/\/doi.org\/10.1371\/journal.pone.0176631.","journal-title":"PLoS ONE"},{"key":"2397_CR109","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1056\/NEJMcp1113996","volume":"368","author":"SP Stabler","year":"2013","unstructured":"Stabler SP. Vitamin B12 deficiency. N Engl J Med. 2013;368:149\u201360. https:\/\/doi.org\/10.1056\/NEJMcp1113996.","journal-title":"N Engl J Med"},{"key":"2397_CR110","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/ibd\/izaf210","volume":"32","author":"JK Salwen-Deremer","year":"2026","unstructured":"Salwen-Deremer JK, Westvold SJ, Aschbrenner K, Smith MT, Siegel CA. Cognitive behavioral therapy for insomnia may improve sleep and pain in Crohn\u2019s disease: a waitlist control pilot trial. Inflamm Bowel Dis. 2026;32:106\u201317. https:\/\/doi.org\/10.1093\/ibd\/izaf210.","journal-title":"Inflamm Bowel Dis"},{"key":"2397_CR111","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/ibd\/izaf116","volume":"31","author":"MM Ter Avest","year":"2025","unstructured":"Ter Avest MM, Huijbers MJ, Horjus CS, R\u00f6mkens TEH, Witteman EM, van Dop WA, et al. Group-delivered mindfulness-based cognitive therapy to reduce psychological distress and improve sleep in patients with inflammatory bowel diseases: a multicenter randomized controlled trial (MindIBD). Inflamm Bowel Dis. 2025;31:3021\u201332. https:\/\/doi.org\/10.1093\/ibd\/izaf116.","journal-title":"Inflamm Bowel Dis"},{"key":"2397_CR112","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1056\/NEJMcp2305655","volume":"391","author":"CM Morin","year":"2024","unstructured":"Morin CM, Buysse DJ. Management of insomnia. N Engl J Med. 2024;391:247\u201358. https:\/\/doi.org\/10.1056\/NEJMcp2305655.","journal-title":"N Engl J Med"},{"key":"2397_CR113","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/apt.70247","volume":"62","author":"S Baillie","year":"2025","unstructured":"Baillie S, Saxena S, Jayasooriya N, Bottle A, Petersen I, Blackwell J, et al. Pain and sedative medication use among individuals with inflammatory bowel disease: a nationwide population-based cohort study. Aliment Pharmacol Ther. 2025;62:732\u201342. https:\/\/doi.org\/10.1111\/apt.70247.","journal-title":"Aliment Pharmacol Ther"},{"key":"2397_CR114","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jama.2025.23247","volume":"335","author":"JW Winkelman","year":"2026","unstructured":"Winkelman JW, Wipper B. Restless legs syndrome: a review. JAMA. 2026;335:703\u201314. https:\/\/doi.org\/10.1001\/jama.2025.23247.","journal-title":"JAMA"},{"key":"2397_CR115","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-020-0746-x","volume":"22","author":"A Canakis","year":"2020","unstructured":"Canakis A, Qazi T. Sleep and fatigue in IBD: an unrecognized but important extra-intestinal manifestation. Curr Gastroenterol Rep. 2020;22:8. https:\/\/doi.org\/10.1007\/s11894-020-0746-x.","journal-title":"Curr Gastroenterol Rep"},{"key":"2397_CR116","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1001\/jama.2026.0872","volume":"335","author":"P Singh","year":"2026","unstructured":"Singh P, Lee A, Sheth NM, Chey WD. Chronic, noninfectious diarrhea: a review. JAMA. 2026;335:1250\u201362. https:\/\/doi.org\/10.1001\/jama.2026.0872.","journal-title":"JAMA"},{"key":"2397_CR117","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/apt.13570","volume":"43","author":"N Mottacki","year":"2016","unstructured":"Mottacki N, Simr\u00e9n M, Bajor A. Review article: bile acid diarrhoea \u2013 pathogenesis, diagnosis and management. Aliment Pharmacol Ther. 2016;43:884\u201398. https:\/\/doi.org\/10.1111\/apt.13570.","journal-title":"Aliment Pharmacol Ther"},{"key":"2397_CR118","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.crohns.2014.05.009","volume":"8","author":"F Beigel","year":"2014","unstructured":"Beigel F, Teich N, Howaldt S, Lammert F, Maul J, Breiteneicher S, et al. Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn\u2019s disease: a randomized, double-blind, placebo-controlled study. J Crohns Colitis. 2014;8:1471\u20139. https:\/\/doi.org\/10.1016\/j.crohns.2014.05.009.","journal-title":"J Crohns Colitis"},{"key":"2397_CR119","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/apt.17988","volume":"59","author":"A Aliu","year":"2024","unstructured":"Aliu A, Bosch DHCA, Keszthelyi D, Rezazadeh Ardabili A, Colombel J-F, Sawyer R, et al. Review article: a practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission. Aliment Pharmacol Ther. 2024;59:1470\u201388. https:\/\/doi.org\/10.1111\/apt.17988.","journal-title":"Aliment Pharmacol Ther"},{"key":"2397_CR120","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/cid\/cix669","volume":"65","author":"AL Shane","year":"2017","unstructured":"Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017;65:e45-80. https:\/\/doi.org\/10.1093\/cid\/cix669.","journal-title":"Clin Infect Dis"},{"key":"2397_CR121","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/MCG.0000000000000049","volume":"48","author":"HN Iskandar","year":"2014","unstructured":"Iskandar HN, Cassell B, Kanuri N, Gyawali CP, Gutierrez A, Dassopoulos T, et al. Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease. J Clin Gastroenterol. 2014;48:423\u20139. https:\/\/doi.org\/10.1097\/MCG.0000000000000049.","journal-title":"J Clin Gastroenterol"},{"key":"2397_CR122","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/MEG.0000000000002768","volume":"36","author":"F Weston","year":"2024","unstructured":"Weston F, Carter B, Powell N, Young AH, Moulton CD. Antidepressant treatment in inflammatory bowel disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2024;36:850\u201360. https:\/\/doi.org\/10.1097\/MEG.0000000000002768.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2397_CR123","doi-asserted-by":"publisher","first-page":"595","DOI":"10.4103\/1735-1995.165969","volume":"20","author":"H Daghaghzadeh","year":"2015","unstructured":"Daghaghzadeh H, Naji F, Afshar H, Sharbafchi MR, Feizi A, Maroufi M, et al. Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: a double-blind controlled study. J Res Med Sci. 2015;20:595\u2013601. https:\/\/doi.org\/10.4103\/1735-1995.165969.","journal-title":"J Res Med Sci"},{"key":"2397_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.880058","volume":"13","author":"C Liang","year":"2022","unstructured":"Liang C, Chen P, Tang Y, Zhang C, Lei N, Luo Y, et al. Venlafaxine as an adjuvant therapy for inflammatory bowel disease patients with anxious and depressive symptoms: a randomized controlled trial. Front Psychiatry. 2022;13:880058. https:\/\/doi.org\/10.3389\/fpsyt.2022.880058.","journal-title":"Front Psychiatry"},{"key":"2397_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012680.pub2","volume":"4","author":"A Mikocka\u2010Walus","year":"2019","unstructured":"Mikocka\u2010Walus A, Prady SL, Pollok J, Esterman AJ, Gordon AL, Knowles S, et al. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Cochrane Database Syst Rev. 2019;4:CD012680. https:\/\/doi.org\/10.1002\/14651858.CD012680.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"2397_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2021.110266","volume":"109","author":"V Oliva","year":"2021","unstructured":"Oliva V, Lippi M, Paci R, Del Fabro L, Delvecchio G, Brambilla P, et al. Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: a systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2021;109:110266. https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110266.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2397_CR127","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/ecco-jcc\/jjw165","volume":"11","author":"A Mikocka-Walus","year":"2017","unstructured":"Mikocka-Walus A, Hughes PA, Bampton P, Gordon A, Campaniello MA, Mavrangelos C, et al. Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn\u2019s disease: a pilot randomized placebo-controlled trial. J Crohns Colitis. 2017;11:509\u201314. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw165.","journal-title":"J Crohns Colitis"},{"key":"2397_CR128","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.14309\/ajg.0000000000002800","volume":"119","author":"I Hanna-Jairala","year":"2024","unstructured":"Hanna-Jairala I, Drossman DA. Central neuromodulators in irritable bowel syndrome: why, how, and when. Am J Gastroenterol. 2024;119:1272\u201384. https:\/\/doi.org\/10.14309\/ajg.0000000000002800.","journal-title":"Am J Gastroenterol"},{"key":"2397_CR129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub3","author":"MPT Lunn","year":"2014","unstructured":"Lunn MPT, Hughes RAC, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014. https:\/\/doi.org\/10.1002\/14651858.CD007115.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"2397_CR130","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41395-018-0222-5","volume":"114","author":"AC Ford","year":"2019","unstructured":"Ford AC, Lacy BE, Harris LA, Quigley EMM, Moayyedi P. Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol. 2019;114:21\u201339. https:\/\/doi.org\/10.1038\/s41395-018-0222-5.","journal-title":"Am J Gastroenterol"},{"key":"2397_CR131","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1745-0179-2-24","volume":"2","author":"AA Mikocka-Walus","year":"2006","unstructured":"Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemiol Ment Health CP EMH. 2006;2:24. https:\/\/doi.org\/10.1186\/1745-0179-2-24.","journal-title":"Clin Pract Epidemiol Ment Health CP EMH."},{"key":"2397_CR132","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/j.cgh.2021.07.006","volume":"19","author":"L Keefer","year":"2021","unstructured":"Keefer L, Ko CW, Ford AC. AGA clinical practice update on management of chronic gastrointestinal pain in disorders of gut\u2013brain interaction: expert review. Clin Gastroenterol Hepatol. 2021;19:2481-2488.e1. https:\/\/doi.org\/10.1016\/j.cgh.2021.07.006.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2397_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2025.102059","volume":"78","author":"U von Arnim","year":"2025","unstructured":"von Arnim U, Scholz K. Fatigue in inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2025;78:102059. https:\/\/doi.org\/10.1016\/j.bpg.2025.102059.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2397_CR134","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1053\/j.gastro.2020.08.060","volume":"160","author":"AN Ananthakrishnan","year":"2021","unstructured":"Ananthakrishnan AN, Nguyen GC, Bernstein CN. AGA clinical practice update on management of inflammatory bowel disease in elderly patients: expert review. Gastroenterology. 2021;160:445\u201351. https:\/\/doi.org\/10.1053\/j.gastro.2020.08.060.","journal-title":"Gastroenterology"},{"key":"2397_CR135","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.cgh.2025.05.019","volume":"23","author":"JD Feuerstein","year":"2025","unstructured":"Feuerstein JD, Rubin DT, Aberra FN, Yarur AJ, Malter L. Appropriate use and complications of corticosteroids in inflammatory bowel disease: a comprehensive review. Clin Gastroenterol Hepatol. 2025;23:2068\u201382. https:\/\/doi.org\/10.1016\/j.cgh.2025.05.019.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2397_CR136","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cgh.2020.08.041","volume":"19","author":"B Niccum","year":"2021","unstructured":"Niccum B, Moninuola O, Miller K, Khalili H. Opioid use among patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021;19:895-907.e4. https:\/\/doi.org\/10.1016\/j.cgh.2020.08.041.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2397_CR137","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.5664\/jcsm.8062","volume":"15","author":"IM Rosen","year":"2019","unstructured":"Rosen IM, Aurora RN, Kirsch DB, Carden KA, Malhotra RK, Ramar K, et al. Chronic opioid therapy and sleep: an American Academy of sleep medicine position statement. J Clin Sleep Med. 2019;15:1671\u20133. https:\/\/doi.org\/10.5664\/jcsm.8062.","journal-title":"J Clin Sleep Med"},{"key":"2397_CR138","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1053\/j.gastro.2025.09.038","volume":"169","author":"FI Scott","year":"2025","unstructured":"Scott FI, Ananthakrishnan AN, Click B, Agrawal M, Syal G, Haydek JP, et al. AGA living clinical practice guideline on the pharmacologic management of moderate-to-severe Crohn\u2019s disease. Gastroenterology. 2025;169:1397\u2013448. https:\/\/doi.org\/10.1053\/j.gastro.2025.09.038.","journal-title":"Gastroenterology"},{"key":"2397_CR139","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/apt.16039","volume":"52","author":"A Vasudevan","year":"2020","unstructured":"Vasudevan A, Parthasarathy N, Con D, Nicolaides S, Apostolov R, Chauhan A, et al. Thiopurines vs methotrexate: comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease. Aliment Pharmacol Ther. 2020;52:1174\u201384. https:\/\/doi.org\/10.1111\/apt.16039.","journal-title":"Aliment Pharmacol Ther"},{"key":"2397_CR140","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1001\/jama.2013.4466","volume":"309","author":"AS Cheifetz","year":"2013","unstructured":"Cheifetz AS. Management of active Crohn disease. JAMA. 2013;309:2150\u20138. https:\/\/doi.org\/10.1001\/jama.2013.4466.","journal-title":"JAMA"},{"key":"2397_CR141","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/apt.13870","volume":"45","author":"M Artom","year":"2017","unstructured":"Artom M, Czuber-Dochan W, Sturt J, Murrells T, Norton C. The contribution of clinical and psychosocial factors to fatigue in 182 patients with inflammatory bowel disease: a cross-sectional study. Aliment Pharmacol Ther. 2017;45:403\u201316. https:\/\/doi.org\/10.1111\/apt.13870.","journal-title":"Aliment Pharmacol Ther"},{"key":"2397_CR142","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/NNR.0000000000000517","volume":"70","author":"SP Davis","year":"2021","unstructured":"Davis SP, Chen D-G, Crane PB, Bolin LP, Johnson LA, Long MD. Influencing factors of inflammatory bowel disease-fatigue: a path analysis model. Nurs Res. 2021;70:256\u201365. https:\/\/doi.org\/10.1097\/NNR.0000000000000517.","journal-title":"Nurs Res"},{"key":"2397_CR143","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1177\/070674371305800702","volume":"58","author":"P Cuijpers","year":"2013","unstructured":"Cuijpers P, Berking M, Andersson G, Quigley L, Kleiboer A, Dobson KS. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry Rev Can Psychiatr. 2013;58:376\u201385. https:\/\/doi.org\/10.1177\/070674371305800702.","journal-title":"Can J Psychiatry Rev Can Psychiatr."},{"key":"2397_CR144","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10608-012-9476-1","volume":"36","author":"SG Hofmann","year":"2012","unstructured":"Hofmann SG, Asnaani A, Vonk IJJ, Sawyer AT, Fang A. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cogn Ther Res. 2012;36:427\u201340. https:\/\/doi.org\/10.1007\/s10608-012-9476-1.","journal-title":"Cogn Ther Res"},{"key":"2397_CR145","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007407.pub4","volume":"8","author":"ACdeC Williams","year":"2020","unstructured":"Williams ACdeC, Fisher E, Hearn L, Eccleston C. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2020;8:CD007407. https:\/\/doi.org\/10.1002\/14651858.CD007407.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"2397_CR146","doi-asserted-by":"publisher","unstructured":"Perlis ML, Smith MT, Benson-Jungquist C, Posner DA, editors. Cognitive behavioral treatment of insomnia [Internet]. New York: Springer-Verlag; 2005. https:\/\/doi.org\/10.1007\/0-387-29180-6(cited 2026 May 18)","DOI":"10.1007\/0-387-29180-6"},{"key":"2397_CR147","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.cpr.2005.04.003","volume":"25","author":"JD Edinger","year":"2005","unstructured":"Edinger JD, Means MK. Cognitive-behavioral therapy for primary insomnia. Clin Psychol Rev. 2005;25:539\u201358. https:\/\/doi.org\/10.1016\/j.cpr.2005.04.003.","journal-title":"Clin Psychol Rev"},{"key":"2397_CR148","doi-asserted-by":"publisher","first-page":"125","DOI":"10.7326\/M15-2175","volume":"165","author":"A Qaseem","year":"2016","unstructured":"Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD, Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165:125\u201333. https:\/\/doi.org\/10.7326\/M15-2175.","journal-title":"Ann Intern Med"},{"key":"2397_CR149","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/ecco-jcc\/jjad128","volume":"18","author":"L Guadagnoli","year":"2024","unstructured":"Guadagnoli L, Horrigan J, Walentynowicz M, Salwen-Deremer JK. Sleep quality drives next day pain and fatigue in adults with inflammatory bowel disease: a short report. J Crohns Colitis. 2024;18:171\u20134. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad128.","journal-title":"J Crohns Colitis"},{"key":"2397_CR150","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jpn3.70066","volume":"81","author":"S Kuzoian","year":"2025","unstructured":"Kuzoian S, Jerson B, Brimacombe M, Schneeberg L, Hyams JS. Sleep tracking and sleep hygiene counseling improve fatigue in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2025;81:62\u20138. https:\/\/doi.org\/10.1002\/jpn3.70066.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2397_CR151","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2021-000805","volume":"8","author":"JK Salwen-Deremer","year":"2021","unstructured":"Salwen-Deremer JK, Smith MT, Aschbrenner KA, Haskell HG, Speed BC, Siegel CA. A pilot feasibility trial of cognitive-behavioural therapy for insomnia in people with inflammatory bowel disease. BMJ Open Gastroenterol. 2021;8:e000805. https:\/\/doi.org\/10.1136\/bmjgast-2021-000805.","journal-title":"BMJ Open Gastroenterol"},{"key":"2397_CR152","doi-asserted-by":"publisher","unstructured":"Vogelaar L, van't Spijker A, Vogelaar T, van Busschbach JJ, Visser MS, Kuipers EJ, et al. Solution focused therapy: A promising new tool in the management of fatigue in Crohn's disease patients: Psychological interventions for the management of fatigue in Crohn's disease. J Crohns Colitis. 2011;5:585\u201391. https:\/\/doi.org\/10.1016\/j.crohns.2011.06.001.","DOI":"10.1016\/j.crohns.2011.06.001"},{"key":"2397_CR153","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40814-019-0538-y","volume":"5","author":"M Artom","year":"2019","unstructured":"Artom M, Czuber-Dochan W, Sturt J, Proudfoot H, Roberts D, Norton C. Cognitive-behavioural therapy for the management of inflammatory bowel disease-fatigue: a feasibility randomised controlled trial. Pilot Feasibility Stud. 2019;5:145. https:\/\/doi.org\/10.1186\/s40814-019-0538-y.","journal-title":"Pilot Feasibility Stud."},{"key":"2397_CR154","doi-asserted-by":"publisher","first-page":"204062231983843","DOI":"10.1177\/2040622319838439","volume":"10","author":"A O'Connor","year":"2019","unstructured":"O\u2019Connor A, Ratnakumaran R, Warren L, Pullen D, Errington A, Gracie DJ, et al. Randomized controlled trial: a pilot study of a psychoeducational intervention for fatigue in patients with quiescent inflammatory bowel disease. Ther Adv Chronic Dis. 2019;10:2040622319838439. https:\/\/doi.org\/10.1177\/2040622319838439.","journal-title":"Ther Adv Chronic Dis."},{"key":"2397_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2024.111949","volume":"187","author":"QM Bredero","year":"2024","unstructured":"Bredero QM, Fleer J, Smink A, Kuiken G, Potjewijd J, Laroy M, et al. Long-term treatment outcomes of mindfulness-based cognitive therapy for fatigue in patients with inflammatory bowel disease: results of a randomized controlled trial. J Psychosom Res. 2024;187:111949. https:\/\/doi.org\/10.1016\/j.jpsychores.2024.111949.","journal-title":"J Psychosom Res"},{"key":"2397_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.landig.2025.100906","volume":"7","author":"R Moss-Morris","year":"2025","unstructured":"Moss-Morris R, Norton C, Hart A, B\u00fcttner FC, Hamborg T, Miller L, et al. Digital cognitive behavioural self-management programme for fatigue, pain, and faecal incontinence in inflammatory bowel disease (IBD-BOOST): a multicentre, parallel, randomised controlled trial. Lancet Dig Health. 2025;7:100906. https:\/\/doi.org\/10.1016\/j.landig.2025.100906.","journal-title":"Lancet Dig Health."},{"key":"2397_CR157","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S0140-6736(22)00877-7","volume":"400","author":"N Meyer","year":"2022","unstructured":"Meyer N, Harvey AG, Lockley SW, Dijk D-J. Circadian rhythms and disorders of the timing of sleep. Lancet. 2022;400:1061\u201378. https:\/\/doi.org\/10.1016\/S0140-6736(22)00877-7.","journal-title":"Lancet"},{"key":"2397_CR158","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1056\/NEJMra1802337","volume":"384","author":"R Allada","year":"2021","unstructured":"Allada R, Bass J. Circadian mechanisms in medicine. N Engl J Med. 2021;384:550\u201361. https:\/\/doi.org\/10.1056\/NEJMra1802337.","journal-title":"N Engl J Med"},{"key":"2397_CR159","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.770491","volume":"8","author":"GR Swanson","year":"2021","unstructured":"Swanson GR, Kochman N, Amin J, Chouhan V, Yim W, Engen PA, et al. Disrupted circadian rest-activity cycles in inflammatory bowel disease are associated with aggressive disease phenotype, subclinical inflammation, and dysbiosis. Front Med. 2021;8:770491. https:\/\/doi.org\/10.3389\/fmed.2021.770491.","journal-title":"Front Med"},{"key":"2397_CR160","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.sleep.2018.08.002","volume":"52","author":"PS Chakradeo","year":"2018","unstructured":"Chakradeo PS, Keshavarzian A, Singh S, Dera AE, Esteban JPG, Lee AA, et al. Chronotype, social jet lag, sleep debt and food timing in inflammatory bowel disease. Sleep Med. 2018;52:188\u201395. https:\/\/doi.org\/10.1016\/j.sleep.2018.08.002.","journal-title":"Sleep Med"},{"key":"2397_CR161","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1093\/sleep\/29.11.1398","volume":"29","author":"CM Morin","year":"1998","unstructured":"Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004). Sleep. 2006;29:1398\u2013414. https:\/\/doi.org\/10.1093\/sleep\/29.11.1398.","journal-title":"Sleep"},{"key":"2397_CR162","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1093\/jcag\/gwae027","volume":"8","author":"Z Post","year":"2025","unstructured":"Post Z, Zilberstein NF, Keshavarzian A. The circadian rhythm as therapeutic target in inflammatory bowel disease. J Can Assoc Gastroenterol. 2025;8:S27-35. https:\/\/doi.org\/10.1093\/jcag\/gwae027.","journal-title":"J Can Assoc Gastroenterol."},{"key":"2397_CR163","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/oby.23672","volume":"31","author":"ENC Manoogian","year":"2023","unstructured":"Manoogian ENC, Laferr\u00e8re B. Time-restricted eating: what we know and where the field is going. Obesity (Silver Spring). 2023;31:7\u20138. https:\/\/doi.org\/10.1002\/oby.23672.","journal-title":"Obesity (Silver Spring)"},{"key":"2397_CR164","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1043783","volume":"9","author":"S Song","year":"2022","unstructured":"Song S, Chen L, Bai M, Wang S, Ye X, Lin Y, et al. Time-restricted feeding ameliorates dextran sulfate sodium-induced colitis via reducing intestinal inflammation. Front Nutr. 2022;9:1043783. https:\/\/doi.org\/10.3389\/fnut.2022.1043783.","journal-title":"Front Nutr"},{"key":"2397_CR165","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41423-024-01189-z","volume":"21","author":"Y Niu","year":"2024","unstructured":"Niu Y, Heddes M, Altaha B, Birkner M, Kleigrewe K, Meng C, et al. Targeting the intestinal circadian clock by meal timing ameliorates gastrointestinal inflammation. Cell Mol Immunol. 2024;21:842\u201355. https:\/\/doi.org\/10.1038\/s41423-024-01189-z.","journal-title":"Cell Mol Immunol"},{"key":"2397_CR166","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2453019","volume":"17","author":"HK Ruple","year":"2025","unstructured":"Ruple HK, Haasis E, Bettenburg A, Maier C, Fritz C, Sch\u00fcle L, et al. The gut microbiota predicts and time-restricted feeding delays experimental colitis. Gut Microbes. 2025;17:2453019. https:\/\/doi.org\/10.1080\/19490976.2025.2453019.","journal-title":"Gut Microbes"},{"key":"2397_CR167","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/MCG.0000000000002220","volume":"60","author":"S Chochinov","year":"2026","unstructured":"Chochinov S, Dolovich C, Ly G, Oketola A, Narvey S, Raman M, et al. A population-based assessment of physical activity and exercise in persons with IBD. J Clin Gastroenterol. 2026;60:432\u201341. https:\/\/doi.org\/10.1097\/MCG.0000000000002220.","journal-title":"J Clin Gastroenterol"},{"key":"2397_CR168","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000371795","volume":"91","author":"P Klare","year":"2015","unstructured":"Klare P, Nigg J, Nold J, Haller B, Krug AB, Mair S, et al. The impact of a ten-week physical exercise program on health-related quality of life in patients with inflammatory bowel disease: a prospective randomized controlled trial. Digestion. 2015;91:239\u201347. https:\/\/doi.org\/10.1159\/000371795.","journal-title":"Digestion"},{"key":"2397_CR169","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12876-019-0936-x","volume":"19","author":"GA Tew","year":"2019","unstructured":"Tew GA, Leighton D, Carpenter R, Anderson S, Langmead L, Ramage J, et al. High-intensity interval training and moderate-intensity continuous training in adults with Crohn\u2019s disease: a pilot randomised controlled trial. BMC Gastroenterol. 2019;19:19. https:\/\/doi.org\/10.1186\/s12876-019-0936-x.","journal-title":"BMC Gastroenterol"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-026-02397-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-026-02397-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-026-02397-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:08:22Z","timestamp":1792073302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-026-02397-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":169,"alternative-id":["2397"],"URL":"https:\/\/doi.org\/10.1007\/s40265-026-02397-9","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"20 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This manuscript was unfunded. Dr Bernstein is supported in part by the Bingham Chair in Gastroenterology. Mr Sareen and Ms Prichodko were funded by the BSc Med Summer Research Program of the University of Manitoba Rady Faculty of Health Sciences, Max Rady College of Medicine.","order":1,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Charles Bernstein is supported by the Bingham Chair in Gastroenterology. Dr. Bernstein has served on advisory Boards for AbbVie Canada, Amgen Canada, Celltrion, Eli Lilly Canada, Ferring Canada, Fresenius-Kabi Canada, JandJ Pharma Canada, Organon Canada,\u00a0Pendopharm\u00a0Canada, Sanofi Canada, Takeda Canada, and Pfizer Canada; Educational grants from\u00a0Abbvie\u00a0Canada, Boston Scientific, Celltrion, Eli Lilly Canada, Ferring Canada, Fresenius Kabi Canada, JandJ Pharma Canada, Pfizer Canada, Takeda Canada, and Speaker\u2019s panel for\u00a0Abbvie\u00a0Canada, JandJ Pharma Canada, Eli Lilly, Fresenius-Kabi, Medtronic Canada, Pfizer Canada, and Takeda Canada. Received research or grant funding from\u00a0Abbvie\u00a0Canada, Celltrion, JandJ Pharma Canada, Pfizer Canada, and Takeda Canada. Dr Graff\u00a0has received\u00a0a\u00a0speaker honorarium from Amgen, and investigator-initiated research from Takeda Canada and Pfizer Canada. The other authors had no conflicts to declare.","order":2,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None was required for this narrative review.","order":3,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None was required.","order":4,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None was required.","order":5,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data are reported in this manuscript","order":6,"name":"Ethics","label":"Availability of data and materials","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":7,"name":"Ethics","label":"Code availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jai Sareen and Madelaine Prichodko wrote the first draft of the manuscript. Jai Sareen, Madelaine Prichodko, Lesley A. Graff, Ali Keshavarzian, Robin M Voigt, and Charles N Bernstein MD all contributed to the outline of the manuscript, to the literature review and the editing of the manuscript.","order":8,"name":"Ethics","label":"Author contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors used generative AI tools (Claude, Anthropic; ChatGPT, OpenAI) solely to assist with language editing and refinement of wording during manuscript preparation. All literature searching, interpretation of the evidence, clinical reasoning, and conclusions are entirely the authors' own. No AI tool was used for drafting original content, data analysis, summarization of sources, translation, or image generation. The authors reviewed and edited all AI-assisted text and take full responsibility for the content of the article.","order":9,"name":"Ethics","label":"AI use","group":{"name":"EthicsHeading","label":"Declarations"}}]}}